EP3514151
PRÓTÍN-KÍNASA-HEMLAR C OG AÐFERÐIR VIÐ AÐ NOTA ÞÁ
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.8.2015EP published:
23.4.2025EP application number:
19160124.4
EP translation filed:
9.7.2025Grant published:
15.8.2025EPO information:
European Patent Register
Max expiry date:
4.8.2035Expiry date:
4.8.2026Next due date:
31.8.2026
Title in English:
PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USELanguage of the patent:
English
Timeline
Today
5.8.2015EP application
23.4.2025EP Publication
9.7.2025Translation submitted
15.8.2025Registration published
4.8.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
LUZZIO, Michael JosephAddress:
Cambridge, MA 02139, US
Name:
PAPILLON, JulienAddress:
Cambridge, MA 02139, US
Name:
VISSER, Michael ScottAddress:
Cambridge, MA 02131, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201462033679 PDate:
6.8.2014Country:
US
Classification
Categories:
C07D 401/14, C07D 413/14, A61K 31/506, A61P 31/04, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 8.7.2025
Expires: 4.8.2026
Payer: Zacco Denmark A/S